OHSU

Tanja Pejovic, M.D., Ph.D.

Head Shot of Tanja Pejovic

Associate Professor

Email: 
click here
Office: 
503 418-4500

Background

Dr. Pejovic's research focuses on understanding the genetic predisposition to ovarian cancer.


Summary of Current Research


Selected Publications

"ER+/PR+/TFF3+/IMP3- immunoprofile distinguishes endometrioid from serous and clear cell carcinomas of the endometrium: A study of 401 cases," Histopathology (Vol: 0, Issue: , Page ) - 2013

"Histologic parameters predictive of disease outcome in women with advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy," Translational Oncology (Vol: 5, Issue: 6, Page 469-474) - 2012

"Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma," Gynecologic Oncology (Vol: 127, Issue: 1, Page 198-201) - 2012

"Pair-Box (PAX8) protein-positive expression is associated with poor disease outcome in women with endometrial cancer," British Journal of Cancer (Vol: 107, Issue: 2, Page 370-374) - 2012

"BRCAness profile of sporadic ovarian cancer predicts disease recurrence," PLoS ONE (Vol: 7, Issue: 1, Page ) - 2012

 

OHSU Knight Cancer Institute

Visit Our Site

For Healthcare Professionals


Contact

  Email Tanja Pejovic

503 418-4500

Memberships & Associations

Fellow, American Congress of Obstetricians and Gynecologists Society of Gynecologic Oncologists Society for Gynecologic Investigations American Society of Clinical Oncologists International Society of Gynecologic Oncologists European Society of Gynecologic Oncologists Society for Gynecologic Oncology, Serbia New Haven Obstetrics and Gynecology Society Swedish Medical Society Oregon Society of Medical Oncologists

My Research Network